Compare · ONTO vs TMO
ONTO vs TMO
Side-by-side comparison of Onto Innovation Inc. (ONTO) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ONTO and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $175.70B, about 13.9x ONTO ($12.60B).
- Over the past year, ONTO is up 154.5% and TMO is up 15.7% - ONTO leads by 138.8 points.
- TMO has been more active in the news (17 items in the past 4 weeks vs 16 for ONTO).
- TMO has more recent analyst coverage (25 ratings vs 19 for ONTO).
- Company
- Onto Innovation Inc.
- Thermo Fisher Scientific Inc
- Price
- $253.36-7.89%
- $472.71-1.94%
- Market cap
- $12.60B
- $175.70B
- 1M return
- -13.74%
- -0.15%
- 1Y return
- +154.51%
- +15.69%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 16
- 17
- Recent ratings
- 19
- 25
Onto Innovation Inc.
Onto Innovation Inc. engages in the design, development, manufacture, and support of process control tools that performs macro defect inspection and metrology, lithography systems, and process control analytical software worldwide. It offers process and yield management solutions, and device packaging and test facilities through standalone systems for macro-defect inspection, packaging lithography, probe card test and analysis, and transparent and opaque thin film measurements; and process control software portfolio that includes solutions for standalone tools, groups of tools, or factory-wide suites. The company also provides spare parts and software licensing services. Its products are used by semiconductor wafer and advanced packaging device manufacturers; silicon wafer; light emitting diode; vertical-cavity surface-emitting laser; micro-electromechanical system; CMOS image sensor; power device; RF filter; data storage; and various industrial and scientific applications. The company was formerly known as Rudolph Technologies, Inc. Onto Innovation Inc. was founded in 1940 and is headquartered in Wilmington, Massachusetts.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest ONTO
- Desjardins initiated coverage on Onto Innovation with a new price target
- SEC Form SD filed by Onto Innovation Inc.
- Director Su May was granted 761 shares, increasing direct ownership by 11% to 7,984 units (SEC Form 4)
- Director Seams Christopher A was granted 761 shares, increasing direct ownership by 2% to 38,513 units (SEC Form 4)
- Director Schwartz Stephen S was granted 761 shares, increasing direct ownership by 27% to 3,536 units (SEC Form 4)
- Director Miller David Brian was granted 761 shares, increasing direct ownership by 6% to 12,692 units (SEC Form 4)
- Director Lynch Susan D was granted 761 shares, increasing direct ownership by 26% to 3,684 units (SEC Form 4)
- Director Kelley Stephen Douglas was granted 761 shares, increasing direct ownership by 14% to 6,384 units (SEC Form 4)
- Onto Innovation Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement
- Onto Innovation Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)